| Naprelan '375' Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Naprelan '375' sodium 412.5 mg | tablet, extended release | oral | 1.0 each | OTC |
Victory Pharma, Inc. Doubling US Sales Force - PR Newswire (press release)
NAPRELAN (naproxen sodium) Controlled Release Tablets are commercially available in 375 mg and 500 mg dosage strengths. NAPRELAN Tablets use Elan's ...
Tue Jul 10 21:15:39 -0400 2007
Oryx Pharmaceuticals Announces Launch of Naprelan - PharmaLive.com (press release)
NAPRELAN(TM) is approved in Canada for the management of signs and symptoms of rheumatoid arthritis and osteoarthritis and is available in strengths of 375 ...
Tue Jul 17 06:33:41 -0400 2007
Oryx Pharmaceuticals announces launch of NAPRELAN(TM) - Canada NewsWire (press release)
NAPRELAN(TM) is approved in Canada for the management of signs and symptoms of rheumatoid arthritis and osteoarthritis and is available in strengths of 375 ...
Mon Jul 16 16:07:24 -0400 2007
naproxen sodium - The sodium salt form of naproxen, a member of the arylacetic acid group of non-steroidal anti-inflammatory drugs (NSAIDs) with anti-inflammatory analgesic and antipyretic properties. Naproxen sodium reversibly and competitively inhibits cyclooxygenases (COX), thereby blocking the conversion of arachidonic acid to pro-inflammatory prostaglandins. This inhibits the formation of prostaglandins that are involved in pain, inflammation and fever.